BIOMAT Database Logo BIOMAT Database Logo

Flushing CVADs: heparin or sodium chloride 0.9%? 2010

Karen Bravery

UI MeSH Term Description Entries
D002405 Catheterization, Central Venous Placement of an intravenous CATHETER in the subclavian, jugular, or other central vein. Central Venous Catheterization,Venous Catheterization, Central,Catheterization, Central,Central Catheterization,Catheterizations, Central,Catheterizations, Central Venous,Central Catheterizations,Central Venous Catheterizations,Venous Catheterizations, Central
D006113 United Kingdom Country in northwestern Europe including Great Britain and the northern one-sixth of the island of Ireland, located between the North Sea and north Atlantic Ocean. The capital is London. Great Britain,Isle of Man
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012965 Sodium Chloride A ubiquitous sodium salt that is commonly used to season food. Sodium Chloride, (22)Na,Sodium Chloride, (24)NaCl

Related Publications

Karen Bravery
Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults.
October 2014, The Cochrane database of systematic reviews,
Karen Bravery
Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial.
June 2012, Critical care medicine,
Karen Bravery
Heparin versus 0.9% sodium chloride intermittent flushing for preventing occlusion in newborns with peripherally inserted central catheters: A systematic review protocol.
January 2022, PloS one,
Karen Bravery
Stability of milrinone in 0.45% sodium chloride, 0.9% sodium chloride, or 5% dextrose injections.
September 1986, American journal of hospital pharmacy,
Karen Bravery
Heparin lock flush solution versus 0.9% sodium chloride injection for maintaining patency.
February 1993, American journal of hospital pharmacy,
Karen Bravery
[Sodium chloride 0.9%: nephrotoxic crystalloid?].
February 2016, Revue medicale suisse,
Karen Bravery
Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children.
November 2015, The Cochrane database of systematic reviews,
Karen Bravery
Efficacy of 0.9% sodium chloride injection with or without heparin sodium for maintaining patency of intravenous catheters in children.
November 1988, Clinical pharmacy,
Karen Bravery
Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devices.
June 1988, Clinical pharmacy,
Karen Bravery
Stability of acetazolamide sodium in 5% dextrose or 0.9% sodium chloride injection.
February 1987, American journal of hospital pharmacy,
Copied contents to your clipboard!